These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1329920)

  • 1. Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent.
    Ofosu FA; Levine M; Craven S; Dewar L; Shafai S; Blajchman MA
    Br J Haematol; 1992 Oct; 82(2):400-5. PubMed ID: 1329920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery.
    Ofosu FA; Leclerc J; Delorme F; Craven S; Shafai S; Frewin L; Blajchman MA
    Br J Haematol; 1992 Oct; 82(2):391-9. PubMed ID: 1329919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in factor VII proteolysis in vivo.
    Ofosu FA; Craven S; Dewar L; Anvari N; Andrew M; Blajchman MA
    Br J Haematol; 1996 Aug; 94(2):407-12. PubMed ID: 8759906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS; Brill-Edwards P; Panju A; Patel A; McGinnis J; Smith F; Dale I; Johnston M; Ofosu F
    Thromb Haemost; 1995 Aug; 74(2):602-5. PubMed ID: 8584991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparin.
    Sørensen JV; Borris LC; Lassen MR; Christiansen HM; Schøtt P; Olsen AD
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):389-92. PubMed ID: 1966794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ; Stewart GJ; White JV
    Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma.
    Schoen P; Lindhout T; Hemker HC
    Br J Haematol; 1992 Jun; 81(2):255-62. PubMed ID: 1322691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of deep-vein thrombosis following total hip replacement surgery with enoxaparin versus unfractionated heparin: a pharmacoeconomic evaluation.
    Menzin J; Richner R; Huse D; Colditz GA; Oster G
    Ann Pharmacother; 1994 Feb; 28(2):271-5. PubMed ID: 8173149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery.
    Falanga A; Ofosu FA; Cortelazzo S; Delaini F; Consonni R; Caccia R; Longatti S; Maran D; Rodeghiero F; Pogliani E
    Br J Haematol; 1993 Dec; 85(4):745-50. PubMed ID: 7918039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin prophylaxis in elective hip surgery.
    Turpie AG
    Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement.
    Hoek JA; Nurmohamed MT; ten Cate JW; Büller HR; Knipscheer HC; Hamelynck KJ; Marti RK; Sturk A
    Thromb Haemost; 1989 Dec; 62(4):1050-2. PubMed ID: 2559485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
    Cziraky MJ; Spinler SA
    Clin Pharm; 1993 Dec; 12(12):892-9. PubMed ID: 8137606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.